Reuters logo
BRIEF-Calithera Biosciences enters into underwriting agreement with Leerink Partners
March 22, 2017 / 10:32 AM / 6 months ago

BRIEF-Calithera Biosciences enters into underwriting agreement with Leerink Partners

March 22 (Reuters) - Calithera Biosciences Inc-

* On March 21 entered into an underwriting agreement with Leerink Partners Llc - SEC filing

* Price to public in offering is $10.25 per share

* Underwriting agreement is relating to issuance and sale of 6.8 million shares of its common stock, par value $0.0001 per share

* Underwriters have agreed to purchase shares from co pursuant to underwriting agreement at a price of $9.635/share Source text: (bit.ly/2n6tXQf) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below